Glenn F. Tilton - May 6, 2022 Form 4 Insider Report for AbbVie Inc. (ABBV)

Role
Director
Signature
Steven L. Scrogham, attorney-in-fact for Glenn F. Tilton
Stock symbol
ABBV
Transactions as of
May 6, 2022
Transactions value $
$0
Form type
4
Date filed
5/9/2022, 05:14 PM
Previous filing
May 3, 2022
Next filing
Jan 19, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABBV Common Stock, $0.01 par value Award $0 +1.42K +3.08% $0.00 47.6K May 6, 2022 Direct F1
holding ABBV Common Stock, $0.01 par value 350 May 6, 2022 By Wife F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These are restricted stock units awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).
F2 The reporting person disclaims beneficial ownership of all securities held by his wife.